Therapy of non-small cell lung cancer in stage IV

被引:1
作者
Deppermann, Karl-Matthias [1 ]
Huber, Rudolf M.
Laack, Eckart
Reck, Martin
Serke, Monika
von Pawel, Joachim
机构
[1] Ruppiner Klinikum GmbH, Klin Pneumol, Neuruppin, Germany
[2] Univ Munich, Med Klin Innenstadt, D-8000 Munich, Germany
[3] Univ Hamburg, Klinikum Eppendorf, Med Klin 2, Hamburg, Germany
[4] Krankenhaus Grosshansdorf, Zentrum Pneumol & Thoraxchirurg, D-2070 Grosshansdorf, Germany
[5] Helios Klinikum Emil von Behring, Klin Pneumol 2, Lungenklin Heckeshorn, Berlin, Germany
[6] Asklepios Fachkliniken Munchen Gauting, Schwerpunkt Onkol, Gauting, Germany
来源
ONKOLOGIE | 2006年 / 29卷
关键词
NSCLC; pharmacology; erlotinib; combination therapy; single agent therapy;
D O I
10.1159/000094950
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:15 / 19
页数:5
相关论文
共 28 条
[1]  
ALBERTI W, 1995, BRIT MED J, V311, P899
[2]  
*ARB BEV KREBSR DT, 2004, KREBS DTSCH 4 UB AKT
[3]   Outcome of patients with a performance status of 2 in the Multicenter Italian Lung Cancer in the Elderly Study (MILES) - Reply [J].
Azzoli, CG ;
Pfister, DG ;
Johnson, DH ;
Somerfield, MR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (24) :5020-5021
[4]  
DADDAIO G, 2005, J CLIN ONCOL, V23, P1882
[5]   Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group [J].
Fossella, F ;
Pereira, JR ;
von Pawel, J ;
Pluzanska, A ;
Gorbounova, V ;
Kaukel, E ;
Mattson, KV ;
Ramlau, R ;
Szczesna, A ;
Fidias, P ;
Millward, M ;
Belani, CP .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) :3016-3024
[6]   Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial [J].
Georgoulias, V ;
Ardavanis, A ;
Tsiafaki, X ;
Agelidou, A ;
Mixalopoulou, P ;
Anagnostopoulou, O ;
Ziotopoulos, P ;
Toubis, M ;
Syrigos, K ;
Samaras, N ;
Polyzos, A ;
Christou, A ;
Kakolyris, S ;
Kouroussis, C ;
Androulakis, N ;
Samonis, G ;
Chatzidaki, D .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) :2937-2945
[7]  
Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66
[8]   Chemotherapy for elderly patients with advanced non-small-cell lung cancer:: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial [J].
Gridelli, C ;
Perrone, F ;
Gallo, C ;
Cigolari, S ;
Rossi, A ;
Piantedosi, F ;
Barbera, S ;
Ferraù, F ;
Piazza, E ;
Rosetti, F ;
Clerici, M ;
Bertetto, O ;
Robbiati, SF ;
Frontini, L ;
Sacco, C ;
Castiglione, F ;
Favaretto, A ;
Novello, S ;
Migliorino, MR ;
Gasparini, G ;
Galetta, D ;
Iaffaioli, RV ;
Gebbia, V .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (05) :362-372
[9]   The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel [J].
Hensing, TA ;
Peterman, AH ;
Schell, MJ ;
Lee, JH ;
Socinski, MA .
CANCER, 2003, 98 (04) :779-788
[10]   Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small-cell lung cancer [J].
Hotta, K ;
Matsuo, K ;
Ueoka, H ;
Kiura, K ;
Tabata, M ;
Tanimoto, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3852-3859